CEO of Tabula Rasa Healthcare Inc (30-Year Financial, Insider Trades) Calvin H Knowlton (insider trades) sold 8,000 shares of TRHC on 08/19/2019 at an average price of $64.13 a share. The total sale was $513,040.
Tabula Rasa HealthCare Inc provides patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk. Tabula Rasa HealthCare Inc has a market cap of $1.4 billion; its shares were traded at around $63.50 with and P/S ratio of 5.86. GuruFocus has detected 3 severe warning signs with Tabula Rasa HealthCare Inc. .
CEO Recent Trades:
- CEO Calvin H Knowlton sold 8,000 shares of TRHC stock on 08/19/2019 at the average price of $64.13. The price of the stock has decreased by 0.98% since.
- CEO Calvin H Knowlton sold 8,000 shares of TRHC stock on 08/07/2019 at the average price of $56.23. The price of the stock has increased by 12.93% since.
CFO Recent Trades:
- CFO Brian W Adams sold 10,000 shares of TRHC stock on 07/31/2019 at the average price of $60. The price of the stock has increased by 5.83% since.
Directors and Officers Recent Trades:
- President Orsula V Knowlton sold 8,000 shares of TRHC stock on 08/19/2019 at the average price of $64.13. The price of the stock has decreased by 0.98% since.
- Director Samira Beckwith sold 3,044 shares of TRHC stock on 08/15/2019 at the average price of $61.32. The price of the stock has increased by 3.56% since.
- Director Gordon Tunstall sold 1,000 shares of TRHC stock on 08/14/2019 at the average price of $62.64. The price of the stock has increased by 1.37% since.
- President Orsula V Knowlton sold 8,000 shares of TRHC stock on 08/07/2019 at the average price of $56.23. The price of the stock has increased by 12.93% since.
For the complete insider trading history of TRHC, click here
.
